Drug comparisons
Dapagliflozin vs Saxagliptin
Dapagliflozin vs Saxagliptin: SGLT2 vs DPP-4 for T2D. Compare efficacy, heart/kidney benefits, side effects, weight loss & Qtern combo.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes deciding between an SGLT2 inhibitor and a DPP-4 inhibitor, especially those with cardiovascular or renal disease.
Bottom line
Dapagliflozin typically provides broader cardiorenal benefits than saxagliptin, yet the optimal drug is determined by individual patient factors.
All medication comparisons